help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schultes, B.
Right arrow Articles by Peters, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultes, B.
Right arrow Articles by Peters, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*METFORMIN HYDROCHLORIDE
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 3 1133-1141
Copyright © 2003 by The Endocrine Society

Modulation of Hunger by Plasma Glucose and Metformin

Bernd Schultes, Kerstin M. Oltmanns, Werner Kern, Horst L. Fehm, Jan Born and Achim Peters

Departments of Internal Medicine I and Neuroendocrinology, University of Luebeck, D-23538 Luebeck, Germany

Address all correspondence and requests for reprints to: Bernd Schultes, M.D., Department of Internal Medicine I, Medical University Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany. E-mail address: schultes{at}kfg.mu-luebeck.de.

The plasma glucose concentration is a major short-term regulator of hunger and food intake. In patients with diabetes, therapies lowering plasma glucose are frequently associated with body weight gain, suggesting that lowered plasma glucose leads to increased feelings of hunger and food intake. However, as many physiological and symptomatic responses to low plasma glucose are attenuated after repeated episodes of hypoglycemia, this may also pertain to feelings of hunger. Here we tested whether the stimulatory effect of low plasma glucose on feelings of hunger is likewise reduced by repeated episodes of hypoglycemia. As metformin has been shown to reduce plasma glucose levels without increasing body weight and also to decrease food intake, we tested for possible interacting effects of this substance with hypoglycemia-induced hunger. Feelings of hunger were assessed by rating scales during 3 consecutive hypoglycemic clamps performed on 2 consecutive d in 15 normal weight men. Subjects were tested once while being treated with 850 mg metformin twice daily and once while receiving placebo. Treatment was started 14 d before the clamp experiments and was performed in a random order and double-blind fashion. Hypoglycemia markedly enhanced feelings of hunger (P < 0.001). However, rated feelings of hunger on the first and last hypoglycemic clamps were comparable (P = 0.304). Compared with placebo, metformin decreased feelings of hunger during hypoglycemia (P = 0.015). This reduction was not associated with a decrease in posthypoglycemic food intake as measured by the number of cookies consumed after the last clamp (P = 0.676). Data indicate that the stimulatory effect of low plasma glucose on hunger is not attenuated after repeated episodes of hypoglycemia, which implies that, in contrast to other symptoms, hunger is not subject to adaptive attenuation upon repeated hypoglycemia. Metformin attenuates hypoglycemia-induced hunger, but does not appear to influence posthypoglycemic food intake.

Abbreviations: VO2, O2 uptake; REE, resting energy expenditure; VCO2, exhaled CO2.




This article has been cited by other articles:


Home page
Hum ReprodHome page
B. Trolle, A. Flyvbjerg, U. Kesmodel, and F.F. Lauszus
Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial
Hum. Reprod., November 1, 2007; 22(11): 2967 - 2973.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Chau-Van, M. Gamba, R. Salvi, R. C. Gaillard, and F. P. Pralong
Metformin Inhibits Adenosine 5'-Monophosphate-Activated Kinase Activation and Prevents Increases in Neuropeptide Y Expression in Cultured Hypothalamic Neurons
Endocrinology, February 1, 2007; 148(2): 507 - 511.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. Schultes, A. Peters, M. Hallschmid, C. Benedict, V. Merl, K. M. Oltmanns, J. Born, H. L. Fehm, and W. Kern
Modulation of Food Intake by Glucose in Patients With Type 2 Diabetes
Diabetes Care, December 1, 2005; 28(12): 2884 - 2889.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society